IRIS
AVAGLIANO, CARMEN
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.592
AS - Asia 1.564
EU - Europa 1.335
SA - Sud America 199
AF - Africa 42
OC - Oceania 4
Totale 4.736
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.523
SG - Singapore 682
RU - Federazione Russa 575
IT - Italia 347
VN - Vietnam 326
CN - Cina 297
BR - Brasile 158
HK - Hong Kong 103
FR - Francia 73
DE - Germania 67
NL - Olanda 60
CA - Canada 49
FI - Finlandia 43
IE - Irlanda 41
GB - Regno Unito 40
IN - India 26
BD - Bangladesh 20
JP - Giappone 19
AR - Argentina 15
ES - Italia 14
ZA - Sudafrica 14
UA - Ucraina 13
TH - Thailandia 12
KR - Corea 11
MX - Messico 10
CI - Costa d'Avorio 9
PH - Filippine 9
TR - Turchia 9
AT - Austria 8
PL - Polonia 8
SE - Svezia 8
BG - Bulgaria 7
EC - Ecuador 7
CZ - Repubblica Ceca 6
IQ - Iraq 6
PK - Pakistan 6
AE - Emirati Arabi Uniti 5
CO - Colombia 5
LT - Lituania 5
CL - Cile 4
ID - Indonesia 4
JM - Giamaica 4
SK - Slovacchia (Repubblica Slovacca) 4
VE - Venezuela 4
AU - Australia 3
BE - Belgio 3
EG - Egitto 3
KZ - Kazakistan 3
PS - Palestinian Territory 3
BO - Bolivia 2
EE - Estonia 2
ET - Etiopia 2
GA - Gabon 2
IL - Israele 2
JO - Giordania 2
KE - Kenya 2
MA - Marocco 2
MY - Malesia 2
NP - Nepal 2
OM - Oman 2
PE - Perù 2
PY - Paraguay 2
RO - Romania 2
UZ - Uzbekistan 2
AL - Albania 1
AO - Angola 1
BB - Barbados 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GH - Ghana 1
GM - Gambi 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LY - Libia 1
MD - Moldavia 1
MK - Macedonia 1
MM - Myanmar 1
MN - Mongolia 1
NI - Nicaragua 1
NO - Norvegia 1
PG - Papua Nuova Guinea 1
PT - Portogallo 1
RS - Serbia 1
SA - Arabia Saudita 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
ZM - Zambia 1
Totale 4.736
Salva come PNG Salva come JPEG
Città #
Singapore 350
San Jose 186
Chandler 160
Ashburn 152
Moscow 147
Beijing 105
Hong Kong 99
Ho Chi Minh City 93
Naples 92
Hanoi 60
Amsterdam 51
Los Angeles 50
Santa Clara 50
Dallas 47
Napoli 42
Hefei 33
Millbury 32
Lauterbourg 31
Dearborn 29
Dong Ket 26
Des Moines 23
Boston 22
Council Bluffs 19
Da Nang 19
Princeton 19
Munich 18
Frankfurt am Main 16
São Paulo 16
Turku 16
Chicago 15
Haiphong 15
New York 15
Tokyo 15
Buffalo 14
Ottawa 13
Houston 12
Montreal 12
Orem 12
Atlanta 11
London 11
Redondo Beach 11
The Dalles 11
Falkenstein 10
Lawrence 10
Milan 10
Toronto 10
Denver 9
Nanjing 9
Dublin 8
Nanchang 8
Wilmington 8
Brooklyn 7
Cagliari 7
Phoenix 7
Rome 7
Seattle 7
Seoul 7
Sofia 7
Stockholm 7
Changsha 6
Helsinki 6
Pune 6
Shenyang 6
Vienna 6
Bangkok 5
Brno 5
Jacksonville 5
Memphis 5
Thái Nguyên 5
Afragola 4
Bacoli 4
Belo Horizonte 4
Charlotte 4
Curitiba 4
Hebei 4
Istanbul 4
Lappeenranta 4
Manchester 4
Menlo Park 4
Mexico City 4
Ninh Bình 4
Norwalk 4
Poplar 4
Redwood City 4
San Vitaliano 4
Shanghai 4
Warsaw 4
Wuhan 4
Baghdad 3
Biên Hòa 3
Brasília 3
Córdoba 3
Frankfurt Am Main 3
Guangzhou 3
Guarulhos 3
Jinan 3
Johannesburg 3
Mumbai 3
Newark 3
Nuremberg 3
Totale 2.475
Salva come PNG Salva come JPEG
Nome #
Phaseolus vulgaris L. Extract: Alpha-amylase inhibition against metabolic syndrome in mice 222
Pharmacokinetic characteristics and pharmacological profile of polyethylenglicole derivatives of palmitoylethanolamide (PEA) 193
Analgesic properties of N-(1-carbomyl 2-phenyl-ethyl)butyramide a new synthetic butyrate pro-drug in a model of acute and visceral pain 190
The novel butyrate derivative phenylalanine-butyramide protects from doxorubicin-induced cardiotoxicity 189
Gut-brain axis: Role of lipids in the regulation of inflammation, pain and CNS diseases 187
Phenylalanine Butyramide Is a New Cosmetic Ingredient with Soothing and Anti-Reddening Potential 181
Characterization of New TRPM8 Modulators in Pain Perception 170
Improvement of Topical Palmitoylethanolamide Anti-Inflammatory Activity by Pegylated Prodrugs 162
Fatty acid acyl ethanolamines and PPAR-alpha in neurodegenerative and neurological diseases. Cellular models of neurodegeneration: preliminary data 153
Peroxisome proliferator-activated receptor (PPAR)-alpha activation produces antidepressant-like effects in mice 151
Oral sodium butyrate supplementation ameliorates paclitaxel-induced behavioral and intestinal dysfunction 149
Central administration of oxytocin reduces hyperalgesia in mice: Implication for cannabinoid and opioid systems. 148
Role of sodium butyrate and of its new prodrug N-(1-carbamoyl-2-phenyl-ethyl) butyramide (FBA) in gastrointestinal transit, castor oil-induced diarrhoea, and croton oil-induced intestinal inflammation 144
Potential Clinical Applications of the Postbiotic Butyrate in Human Skin Diseases 144
Uncovering the role of the lipid receptor PPAR-alpha on higher brain functions 141
Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-α receptor activation in a genetic model of absence epilepsy. 135
Palmitoylethanolamide Protects Against the Amyloid-β25-35-Induced Learning and Memory Impairment in Mice, an Experimental Model of Alzheimer Disease. 133
Sodium butyrate and its synthetic amide derivative modulate nociceptive behaviors in mice 133
Intestinal inflammation increases convulsant activity and reduces antiepileptic drug efficacy in a mouse model of epilepsy 132
Ketogal: A Derivative Ketorolac Molecule with Minor Ulcerogenic and Renal Toxicity 132
Peroxisome proliferator-activated receptor alpha plays a crucial role in behavioral repetition and cognitive flexibility in mice 127
Nutraceuticals: An integrative approach to starve Parkinson’s disease 126
Galactosyl prodrug of palmitoylethanolamide: Synthesis, stability, cell permeation and cytoprotective activity 123
Pharmacokinetic-pharmacodynamic influence of N-palmitoylethanolamine, arachidonyl-2′-chloroethylamide and WIN 55,212-2 on the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice 122
Antinociceptive effect of two novel transient receptor potential melastatin 8 antagonists in acute and chronic pain models in rat 120
Effects of Chronic Oral Probiotic Treatment in Paclitaxel-Induced Neuropathic Pain 118
Biological Profile of Two Gentiana lutea L. Metabolites Using Computational Approaches and In Vitro Tests 114
Effects of a probiotic suspension Symprove™ on a rat early-stage Parkinson's disease model 109
The Beneficial Effects of Ultramicronized Palmitoylethanolamide in the Management of Neuropathic Pain and Associated Mood Disorders Induced by Paclitaxel in Mice 106
The Protective Role of Butyrate against Obesity and Obesity-Related Diseases 104
Phaseolus vulgaris extract ameliorates high-fat diet-induced colonic barrier dysfunction and inflammation in mice by regulating peroxisome proliferator-activated receptor expression and butyrate levels 102
Response to comment by Juan Segura-Aguilar: New preclinical model are required to discover neuroprotective compound in Parkinson's disease 97
Modulation of Pain Sensitivity by Chronic Consumption of Highly Palatable Food Followed by Abstinence: Emerging Role of Fatty Acid Amide Hydrolase 96
Dual-Hit Model of Parkinson's Disease: Impact of Dysbiosis on 6-Hydroxydopamine-Insulted Mice-Neuroprotective and Anti-Inflammatory Effects of Butyrate. [*Avagliano C. and Coretti L. co-first authors] 91
Palmitoylethanolamide protects mice against 6-OHDA-induced neurotoxicity and endoplasmic reticulum stress: In vivo and in vitro evidence 90
Expression of VEGF-A/VEGFR-2 pathway in feline oral squamous cell carcinoma in vitro and anti-tumour effect of Bevacizumab in a xenograft model 3
Totale 4.837
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.838
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.838
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022261 2 1 2 22 25 3 7 8 33 23 59 76
2022/2023414 30 16 18 42 52 43 6 56 56 58 31 6
2023/2024207 11 30 33 15 10 18 14 30 1 8 21 16
2024/20251.161 62 37 4 21 27 50 120 97 65 104 472 102
2025/20262.216 224 121 274 203 437 85 211 108 270 174 59 50
2026/2027123 123 0 0 0 0 0 0 0 0 0 0 0
Totale 4.837